19.62
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Upstream Bio's (UPB) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Rising Interest Rates Hurt Vintage Coffee and Beverages Limiteds Profit MarginsMonthly Performance Summary & Free Stop-Loss Planning for Your Portfolio - earlytimes.in
Measuring Upstream Bio Inc.’s beta against major indicesJuly 2025 News Drivers & Risk Adjusted Buy/Sell Alerts - newser.com
What does recent volatility data suggest for Upstream Bio Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
What drives Upstream Bio Inc stock priceVolume Weighted Average Price & Plan Your Future With Strategic Investing - earlytimes.in
Visualizing Upstream Bio Inc. stock with heatmapsJuly 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
Can volume confirm reversal in Upstream Bio Inc.Trade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Applying Elliott Wave Theory to Upstream Bio Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past Week - Yahoo
Assessing Upstream Bio (UPB) Valuation After New Verekitug Phase 2 Data and Investor Interest Surge - Sahm
Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Why Upstream Bio (UPB) Is Up 14.0% After Positive Phase 2 Verekitug Data and Novel Dosing Approach - Sahm
News impact scoring models applied to Upstream Bio Inc.2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Is Upstream Bio Inc. forming a reversal patternJuly 2025 Update & Community Supported Trade Ideas - newser.com
Is Upstream Bio Inc. stock attractive for passive investorsMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Earnings visualization tools for Upstream Bio Inc.July 2025 Earnings & Trade Opportunity Analysis - newser.com
Why retail investors pile into Upstream Bio Inc. stock2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Upstream Bio Inc Stock Analysis and ForecastPrice Channel Trading & Free Popular Stock Picks Selection - earlytimes.in
Is Upstream Bio Inc. building a consolidation baseTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Upstream Bio (NASDAQ:UPB) Trading 4.2% HigherStill a Buy? - MarketBeat
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress - The Manila Times
Upstream Bio Presents Data Showing Structural and - GlobeNewswire
24-Week TSLP Inhibition: Upstream Bio's Verekitug Shows Breakthrough Respiratory Disease Treatment Data - Stock Titan
Upstream Bio, Inc. $UPB Shares Sold by Goldman Sachs Group Inc. - Defense World
자본화:
|
볼륨(24시간):